Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study

Helicobacter Pylori

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)

Helicobacter.

Auttajaroon J, Vilaichone RK, Chotivitayatarakorn P, Mahachai V

doi: 10.1111/hel.12615.

The association between Helicobacter pylori seropositivity and risk of new-onset diabetes: a prospective cohort study

Diabetologia.

Zhou M, Liu J, Qi Y, Wang M, Wang Y, Zhao F, Hao Y, Zhao D

doi: 10.1007/s00125-017-4465-2.

Helicobacter Pylori

N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication

Cochrane Database Syst Rev.

Fontes LES, Martimbianco ALC, Zanin C, Riera R

doi: 10.1002/14651858.

Helicobacter Pylori

Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children

Helicobacter.

Zhou Y, Ye Z, Wang Y, Zhang Y, Tang Z, Yan W, Jiang Y, Huang Y

doi: 10.1111/hel.12679.

Helicobacter Pylori

The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis

Helicobacter.

Zou Y, Qian X, Liu X, Song Y, Song C, Wu S, An Y, Yuan R, Wang Y, Xie Y

doi: 10.1111/hel.12714.

Gastrointestinal CancerHelicobacter Pylori

Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study

Gastroenterology.

Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS

doi: 10.1053/j.gastro.2019.10.019.

Helicobacter Pylori

Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children

Helicobacter

Kotilea K, Cadranel S, Salame A, Nguyen J, Mahler T, Miendje Deyi VY, Verset L, Bontems P

doi: 10.1111/hel.12825

Helicobacter Pylori

Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection

Helicobacter

Kim YJ, Chung WC, Kim DB

doi: 10.1111/hel.12792

Helicobacter Pylori

PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis

Helicobacter

Li C, Shi Y, Suo B, Tian X, Zhou L, Song Z

doi: 10.1111/hel.12816

Related content

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)

The association between Helicobacter pylori seropositivity and risk of new-onset diabetes: a prospective cohort study

N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication

Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children

The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis

Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study

Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children

Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection

PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis